-
1
-
-
1842587885
-
C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease
-
Danesh J., Wheeler J.G., Hirschfield G.M., Eda S., Eiriksdottir G., Rumley A., et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004, 350:1387-1397.
-
(2004)
N Engl J Med
, vol.350
, pp. 1387-1397
-
-
Danesh, J.1
Wheeler, J.G.2
Hirschfield, G.M.3
Eda, S.4
Eiriksdottir, G.5
Rumley, A.6
-
2
-
-
3042677716
-
C-reactive protein: risk marker or mediator in atherothrombosis?
-
Jialal I., Devaraj S., Venugopal S.K. C-reactive protein: risk marker or mediator in atherothrombosis?. Hypertension 2004, 44:6-11.
-
(2004)
Hypertension
, vol.44
, pp. 6-11
-
-
Jialal, I.1
Devaraj, S.2
Venugopal, S.K.3
-
3
-
-
0042744797
-
C-reactive protein: a critical update
-
Pepys M.B., Hirschfield G.M. C-reactive protein: a critical update. J Clin Invest 2003, 111:1805-1812.
-
(2003)
J Clin Invest
, vol.111
, pp. 1805-1812
-
-
Pepys, M.B.1
Hirschfield, G.M.2
-
4
-
-
0037078969
-
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events
-
Ridker P.M., Rifai N., Rose L., Buring J.E., Cook N.R. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002, 347:1557-1565.
-
(2002)
N Engl J Med
, vol.347
, pp. 1557-1565
-
-
Ridker, P.M.1
Rifai, N.2
Rose, L.3
Buring, J.E.4
Cook, N.R.5
-
5
-
-
0142095224
-
C-reactive protein and atherothrombosis--beyond a biomarker: an actual partaker of lesion formation
-
[discussion R1257-1258]
-
Verma S., Yeh E.T. C-reactive protein and atherothrombosis--beyond a biomarker: an actual partaker of lesion formation. Am J Physiol Regul Integr Comp Physiol 2003, 285:R1253-R1256. [discussion R1257-1258].
-
(2003)
Am J Physiol Regul Integr Comp Physiol
, vol.285
-
-
Verma, S.1
Yeh, E.T.2
-
6
-
-
0035022924
-
Is C-reactive protein an independent risk factor for essential hypertension?
-
Bautista L.E., Lopez-Jaramillo P., Vera L.M., Casas J.P., Otero A.P., Guaracao A.I. Is C-reactive protein an independent risk factor for essential hypertension?. J Hypertens 2001, 19:857-861.
-
(2001)
J Hypertens
, vol.19
, pp. 857-861
-
-
Bautista, L.E.1
Lopez-Jaramillo, P.2
Vera, L.M.3
Casas, J.P.4
Otero, A.P.5
Guaracao, A.I.6
-
7
-
-
0036901493
-
C-reactive protein predicts progression of atherosclerosis measured at various sites in the arterial tree: the Rotterdam study
-
van der Meer I.M., de Maat M.P.M., Hak A.E., Kiliaan A.J., del Sol A.I., Van der Kuip D.A.M., et al. C-reactive protein predicts progression of atherosclerosis measured at various sites in the arterial tree: the Rotterdam study. Stroke 2002, 33:2750-2755.
-
(2002)
Stroke
, vol.33
, pp. 2750-2755
-
-
van der Meer, I.M.1
de Maat, M.P.M.2
Hak, A.E.3
Kiliaan, A.J.4
del Sol, A.I.5
Van der Kuip, D.A.M.6
-
8
-
-
85021062648
-
Serologucal reactions in pneumonia with a non-protein somatic fraction of pneumococcus
-
Tillett W.S., Francis T. Serologucal reactions in pneumonia with a non-protein somatic fraction of pneumococcus. J Exp Med 1930, 52:561-571.
-
(1930)
J Exp Med
, vol.52
, pp. 561-571
-
-
Tillett, W.S.1
Francis, T.2
-
10
-
-
0037180771
-
Inflammation in atherosclerosis
-
Libby P. Inflammation in atherosclerosis. Nature 2002, 420:868-874.
-
(2002)
Nature
, vol.420
, pp. 868-874
-
-
Libby, P.1
-
11
-
-
0042367742
-
Preanalytic and analytic sources of variations in C-reactive protein measurement: implications for cardiovascular disease risk assessment
-
Ledue T.B., Rifai N. Preanalytic and analytic sources of variations in C-reactive protein measurement: implications for cardiovascular disease risk assessment. Clin Chem 2003, 49:1258-1271.
-
(2003)
Clin Chem
, vol.49
, pp. 1258-1271
-
-
Ledue, T.B.1
Rifai, N.2
-
12
-
-
0030956673
-
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
-
Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997, 336:973-979.
-
(1997)
N Engl J Med
, vol.336
, pp. 973-979
-
-
Ridker, P.M.1
Cushman, M.2
Stampfer, M.J.3
Tracy, R.P.4
Hennekens, C.H.5
-
13
-
-
0034681920
-
Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men
-
Ridker P.M., Rifai N., Stampfer M.J., Hennekens C.H. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000, 101:1767-1772.
-
(2000)
Circulation
, vol.101
, pp. 1767-1772
-
-
Ridker, P.M.1
Rifai, N.2
Stampfer, M.J.3
Hennekens, C.H.4
-
14
-
-
0032566401
-
Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women
-
Ridker P.M., Buring J.E., Shih J., Matias M., Hennekens C.H. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998, 98:731-733.
-
(1998)
Circulation
, vol.98
, pp. 731-733
-
-
Ridker, P.M.1
Buring, J.E.2
Shih, J.3
Matias, M.4
Hennekens, C.H.5
-
15
-
-
1642277853
-
C-reactive protein modulates risk prediction based on the framingham score: implications for future risk assessment: results from a large cohort study in Southern Germany
-
Koenig W., Lowel H., Baumert J., Meisinger C. C-reactive protein modulates risk prediction based on the framingham score: implications for future risk assessment: results from a large cohort study in Southern Germany. Circulation 2004, 109:1349-1353.
-
(2004)
Circulation
, vol.109
, pp. 1349-1353
-
-
Koenig, W.1
Lowel, H.2
Baumert, J.3
Meisinger, C.4
-
16
-
-
1342331006
-
Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study
-
Ballantyne C.M., Hoogeveen R.C., Bang H., Coresh J., Folsom A.R., Heiss G., et al. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Circulation 2004, 109:837-842.
-
(2004)
Circulation
, vol.109
, pp. 837-842
-
-
Ballantyne, C.M.1
Hoogeveen, R.C.2
Bang, H.3
Coresh, J.4
Folsom, A.R.5
Heiss, G.6
-
17
-
-
56749106312
-
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein
-
Ridker P.M., Danielson E., Fonseca F.A., Genest J., Gotto A.M., Kastelein J.J., et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008, 359:2195-2207.
-
(2008)
N Engl J Med
, vol.359
, pp. 2195-2207
-
-
Ridker, P.M.1
Danielson, E.2
Fonseca, F.A.3
Genest, J.4
Gotto, A.M.5
Kastelein, J.J.6
-
18
-
-
63649095045
-
Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial
-
Ridker P.M., Danielson E., Fonseca F.A., Genest J., Gotto A.M., Kastelein J.J., et al. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet 2009, 373:1175-1182.
-
(2009)
Lancet
, vol.373
, pp. 1175-1182
-
-
Ridker, P.M.1
Danielson, E.2
Fonseca, F.A.3
Genest, J.4
Gotto, A.M.5
Kastelein, J.J.6
-
19
-
-
73349104939
-
Does elevated C-reactive protein cause human atherothrombosis? Novel insights from genetics, intervention trials, and elsewhere
-
Nordestgaard B.G. Does elevated C-reactive protein cause human atherothrombosis? Novel insights from genetics, intervention trials, and elsewhere. Curr Opin Lipidol 2009, 20:393-401.
-
(2009)
Curr Opin Lipidol
, vol.20
, pp. 393-401
-
-
Nordestgaard, B.G.1
-
20
-
-
84867164377
-
C-reactive protein, fibrinogen, and cardiovascular disease prediction
-
Kaptoge S., Di Angelantonio E., Pennells L., Wood A.M., White I.R., Gao P., et al. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med 2010, 367:1310-1320.
-
(2010)
N Engl J Med
, vol.367
, pp. 1310-1320
-
-
Kaptoge, S.1
Di Angelantonio, E.2
Pennells, L.3
Wood, A.M.4
White, I.R.5
Gao, P.6
-
21
-
-
80051964418
-
Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study
-
Blaha M.J., Budoff M.J., DeFilippis A.P., Blankstein R., Rivera J.J., Agatston A., et al. Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study. Lancet 2011, 378:684-692.
-
(2011)
Lancet
, vol.378
, pp. 684-692
-
-
Blaha, M.J.1
Budoff, M.J.2
DeFilippis, A.P.3
Blankstein, R.4
Rivera, J.J.5
Agatston, A.6
-
22
-
-
84861480931
-
The absence of coronary artery calcification does not rule out the presence of significant coronary artery disease in Asian patients with acute chest pain
-
Yoon Y., Chang S.-A., Choi S., Chun E.-J., Cho Y.-S., Youn T.-J., et al. The absence of coronary artery calcification does not rule out the presence of significant coronary artery disease in Asian patients with acute chest pain. Int J Cardiovasc Imaging (formerly Cardiac Imaging) 2012, 28:389-398.
-
(2012)
Int J Cardiovasc Imaging (formerly Cardiac Imaging)
, vol.28
, pp. 389-398
-
-
Yoon, Y.1
Chang, S.-A.2
Choi, S.3
Chun, E.-J.4
Cho, Y.-S.5
Youn, T.-J.6
-
23
-
-
84865369143
-
Can C-reactive protein predict cardiovascular events in asymptomatic patients? Analysis based on plaque characterization
-
Park H.E., Cho G.Y., Chun E.J., Choi S.I., Lee S.P., Kim H.K., et al. Can C-reactive protein predict cardiovascular events in asymptomatic patients? Analysis based on plaque characterization. Atherosclerosis 2012, 224:201-207.
-
(2012)
Atherosclerosis
, vol.224
, pp. 201-207
-
-
Park, H.E.1
Cho, G.Y.2
Chun, E.J.3
Choi, S.I.4
Lee, S.P.5
Kim, H.K.6
-
24
-
-
38849140840
-
Is raising HDL a futile strategy for atheroprotection?
-
Joy T., Hegele R.A. Is raising HDL a futile strategy for atheroprotection?. Nat Rev Drug Discov 2008, 7:143-155.
-
(2008)
Nat Rev Drug Discov
, vol.7
, pp. 143-155
-
-
Joy, T.1
Hegele, R.A.2
-
25
-
-
84868214704
-
High-density lipoprotein cholesterol, high-sensitivity C-reactive protein, and cardiovascular disease in United States adults
-
Bilhorn K.R., Luo Y., Lee B.T., Wong N.D. High-density lipoprotein cholesterol, high-sensitivity C-reactive protein, and cardiovascular disease in United States adults. Am J Cardiol 2012, 110(10):1467-1477.
-
(2012)
Am J Cardiol
, vol.110
, Issue.10
, pp. 1467-1477
-
-
Bilhorn, K.R.1
Luo, Y.2
Lee, B.T.3
Wong, N.D.4
-
26
-
-
70350360003
-
2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations
-
Genest J., McPherson R., Frohlich J., Anderson T., Campbell N., Carpentier A., et al. 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations. Can J Cardiol 2009, 25:567-579.
-
(2009)
Can J Cardiol
, vol.25
, pp. 567-579
-
-
Genest, J.1
McPherson, R.2
Frohlich, J.3
Anderson, T.4
Campbell, N.5
Carpentier, A.6
-
27
-
-
78650708490
-
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
-
Greenland P., Alpert J.S., Beller G.A., Benjamin E.J., Budoff M.J., Fayad Z.A., et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2010, 122:2748-2764.
-
(2010)
Circulation
, vol.122
, pp. 2748-2764
-
-
Greenland, P.1
Alpert, J.S.2
Beller, G.A.3
Benjamin, E.J.4
Budoff, M.J.5
Fayad, Z.A.6
-
28
-
-
84867164377
-
C-reactive protein, fibrinogen, and cardiovascular disease prediction
-
Kaptoge S., Di Angelantonio E., Pennells L., Wood A.M., White I.R., Gao P., et al. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med 2012, 367:1310-1320.
-
(2012)
N Engl J Med
, vol.367
, pp. 1310-1320
-
-
Kaptoge, S.1
Di Angelantonio, E.2
Pennells, L.3
Wood, A.M.4
White, I.R.5
Gao, P.6
-
29
-
-
0242349760
-
Endothelial function testing as a biomarker of vascular disease
-
Verma S., Buchanan M.R., Anderson T.J. Endothelial function testing as a biomarker of vascular disease. Circulation 2003, 108:2054-2059.
-
(2003)
Circulation
, vol.108
, pp. 2054-2059
-
-
Verma, S.1
Buchanan, M.R.2
Anderson, T.J.3
-
30
-
-
0242318334
-
Biomarkers of vascular disease linking inflammation to endothelial activation: Part II
-
Szmitko P.E., Wang C.H., Weisel R.D., Jeffries G.A., Anderson T.J., Verma S. Biomarkers of vascular disease linking inflammation to endothelial activation: Part II. Circulation 2003, 108:2041-2048.
-
(2003)
Circulation
, vol.108
, pp. 2041-2048
-
-
Szmitko, P.E.1
Wang, C.H.2
Weisel, R.D.3
Jeffries, G.A.4
Anderson, T.J.5
Verma, S.6
-
31
-
-
70849095298
-
C-reactive protein impairs the endothelial glycocalyx resulting in endothelial dysfunction
-
Devaraj S., Yun J.M., Adamson G., Galvez J., Jialal I. C-reactive protein impairs the endothelial glycocalyx resulting in endothelial dysfunction. Cardiovasc Res 2009, 84:479-484.
-
(2009)
Cardiovasc Res
, vol.84
, pp. 479-484
-
-
Devaraj, S.1
Yun, J.M.2
Adamson, G.3
Galvez, J.4
Jialal, I.5
-
32
-
-
69249242832
-
Human C-reactive protein induces endothelial dysfunction and uncoupling of eNOS in vivo
-
Hein T.W., Singh U., Vasquez-Vivar J., Devaraj S., Kuo L., Jialal I. Human C-reactive protein induces endothelial dysfunction and uncoupling of eNOS in vivo. Atherosclerosis 2009, 206:61-68.
-
(2009)
Atherosclerosis
, vol.206
, pp. 61-68
-
-
Hein, T.W.1
Singh, U.2
Vasquez-Vivar, J.3
Devaraj, S.4
Kuo, L.5
Jialal, I.6
-
33
-
-
0141885287
-
C-Reactive Protein Decreases Prostacyclin Release From Human Aortic Endothelial Cells
-
Venugopal S.K., Devaraj S., Jialal I. C-Reactive Protein Decreases Prostacyclin Release From Human Aortic Endothelial Cells. Circulation 2003, 108:1676-1678.
-
(2003)
Circulation
, vol.108
, pp. 1676-1678
-
-
Venugopal, S.K.1
Devaraj, S.2
Jialal, I.3
-
34
-
-
0033813079
-
C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis
-
Torzewski M., Rist C., Mortensen R.F., Zwaka T.P., Bienek M., Waltenberger J., et al. C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arterioscler Thromb Vasc Biol 2000, 20:2094-2099.
-
(2000)
Arterioscler Thromb Vasc Biol
, vol.20
, pp. 2094-2099
-
-
Torzewski, M.1
Rist, C.2
Mortensen, R.F.3
Zwaka, T.P.4
Bienek, M.5
Waltenberger, J.6
-
35
-
-
0032786558
-
Coronary C-reactive protein distribution: its relation to development of atherosclerosis
-
Zhang Y.X., Cliff W.J., Schoefl G.I., Higgins G. Coronary C-reactive protein distribution: its relation to development of atherosclerosis. Atherosclerosis 1999, 145:375-379.
-
(1999)
Atherosclerosis
, vol.145
, pp. 375-379
-
-
Zhang, Y.X.1
Cliff, W.J.2
Schoefl, G.I.3
Higgins, G.4
-
36
-
-
0034739462
-
Direct proinflammatory effect of C-reactive protein on human endothelial cells
-
Pasceri V., Willerson J.T., Yeh E.T. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000, 102:2165-2168.
-
(2000)
Circulation
, vol.102
, pp. 2165-2168
-
-
Pasceri, V.1
Willerson, J.T.2
Yeh, E.T.3
-
37
-
-
33746087046
-
C-reactive protein promotes platelet adhesion to endothelial cells: a potential pathway in atherothrombosis
-
Yaron G., Brill A., Dashevsky O., Yosef-Levi I.M., Grad E., Danenberg H.D., et al. C-reactive protein promotes platelet adhesion to endothelial cells: a potential pathway in atherothrombosis. Br J Haematol 2006, 134:426-431.
-
(2006)
Br J Haematol
, vol.134
, pp. 426-431
-
-
Yaron, G.1
Brill, A.2
Dashevsky, O.3
Yosef-Levi, I.M.4
Grad, E.5
Danenberg, H.D.6
-
38
-
-
2442661930
-
Endothelial microparticles as markers of endothelial dysfunction
-
Horstman L.L., Jy W., Jimenez J.J., Ahn Y.S. Endothelial microparticles as markers of endothelial dysfunction. Front Biosci 2004, 9:1118-1135.
-
(2004)
Front Biosci
, vol.9
, pp. 1118-1135
-
-
Horstman, L.L.1
Jy, W.2
Jimenez, J.J.3
Ahn, Y.S.4
-
39
-
-
82755162429
-
C-reactive protein induces release of both endothelial microparticles and circulating endothelial cells in vitro and in vivo: further evidence of endothelial dysfunction
-
Devaraj S., Kumaresan P.R., Jialal I. C-reactive protein induces release of both endothelial microparticles and circulating endothelial cells in vitro and in vivo: further evidence of endothelial dysfunction. Clin Chem 2011, 57:1757-1761.
-
(2011)
Clin Chem
, vol.57
, pp. 1757-1761
-
-
Devaraj, S.1
Kumaresan, P.R.2
Jialal, I.3
-
40
-
-
38049021500
-
Transgenic human CRP is not pro-atherogenic, pro-atherothrombotic or pro-inflammatory in apoE-/- mice
-
Tennent G.A., Hutchinson W.L., Kahan M.C., Hirschfield G.M., Gallimore J.R., Lewin J., et al. Transgenic human CRP is not pro-atherogenic, pro-atherothrombotic or pro-inflammatory in apoE-/- mice. Atherosclerosis 2008, 196:248-255.
-
(2008)
Atherosclerosis
, vol.196
, pp. 248-255
-
-
Tennent, G.A.1
Hutchinson, W.L.2
Kahan, M.C.3
Hirschfield, G.M.4
Gallimore, J.R.5
Lewin, J.6
-
41
-
-
35348836491
-
Human C-reactive protein slows atherosclerosis development in a mouse model with human-like hypercholesterolemia
-
Kovacs A., Tornvall P., Nilsson R., Tegner J., Hamsten A., Bjorkegren J. Human C-reactive protein slows atherosclerosis development in a mouse model with human-like hypercholesterolemia. Proc Natl Acad Sci U S A 2007, 104:13768-13773.
-
(2007)
Proc Natl Acad Sci U S A
, vol.104
, pp. 13768-13773
-
-
Kovacs, A.1
Tornvall, P.2
Nilsson, R.3
Tegner, J.4
Hamsten, A.5
Bjorkegren, J.6
-
42
-
-
1042301971
-
C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice
-
Paul A., Ko K.W., Li L., Yechoor V., McCrory M.A., Szalai A.J., et al. C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. Circulation 2004, 109:647-655.
-
(2004)
Circulation
, vol.109
, pp. 647-655
-
-
Paul, A.1
Ko, K.W.2
Li, L.3
Yechoor, V.4
McCrory, M.A.5
Szalai, A.J.6
-
43
-
-
23844479596
-
Native C-reactive protein increases whereas modified C-reactive protein reduces atherosclerosis in apolipoprotein E-knockout mice
-
Schwedler S.B., Amann K., Wernicke K., Krebs A., Nauck M., Wanner C., et al. Native C-reactive protein increases whereas modified C-reactive protein reduces atherosclerosis in apolipoprotein E-knockout mice. Circulation 2005, 112:1016-1023.
-
(2005)
Circulation
, vol.112
, pp. 1016-1023
-
-
Schwedler, S.B.1
Amann, K.2
Wernicke, K.3
Krebs, A.4
Nauck, M.5
Wanner, C.6
-
44
-
-
23244460046
-
Role of C-reactive protein in atherogenesis: can the apolipoprotein E knockout mouse provide the answer?
-
Reifenberg K., Lehr H.A., Baskal D., Wiese E., Schaefer S.C., Black S., et al. Role of C-reactive protein in atherogenesis: can the apolipoprotein E knockout mouse provide the answer?. Arterioscler Thromb Vasc Biol 2005, 25:1641-1646.
-
(2005)
Arterioscler Thromb Vasc Biol
, vol.25
, pp. 1641-1646
-
-
Reifenberg, K.1
Lehr, H.A.2
Baskal, D.3
Wiese, E.4
Schaefer, S.C.5
Black, S.6
-
45
-
-
0038447922
-
Plasma concentration of C-reactive protein and the calculated Framingham coronary heart disease risk score
-
Albert M.A., Glynn R.J., Ridker P.M. Plasma concentration of C-reactive protein and the calculated Framingham coronary heart disease risk score. Circulation 2003, 108:161-165.
-
(2003)
Circulation
, vol.108
, pp. 161-165
-
-
Albert, M.A.1
Glynn, R.J.2
Ridker, P.M.3
-
46
-
-
0035879702
-
Association of C-reactive protein with markers of prevalent atherosclerotic disease
-
Folsom A., Pankow J., Tracy R., Arnett D., Peacock J., Hong Y., et al. Association of C-reactive protein with markers of prevalent atherosclerotic disease. Am J Cardiol 2001, 88:112-117.
-
(2001)
Am J Cardiol
, vol.88
, pp. 112-117
-
-
Folsom, A.1
Pankow, J.2
Tracy, R.3
Arnett, D.4
Peacock, J.5
Hong, Y.6
-
47
-
-
33644861804
-
Relationship between C-reactive protein and subclinical atherosclerosis: the Dallas Heart Study
-
Khera A., de Lemos J.A., Peshock R.M., Lo H.S., Stanek H.G., Murphy S.A., et al. Relationship between C-reactive protein and subclinical atherosclerosis: the Dallas Heart Study. Circulation 2006, 113:38-43.
-
(2006)
Circulation
, vol.113
, pp. 38-43
-
-
Khera, A.1
de Lemos, J.A.2
Peshock, R.M.3
Lo, H.S.4
Stanek, H.G.5
Murphy, S.A.6
-
48
-
-
26244452196
-
Lifecourse socioeconomic position, C-reactive protein, and carotid intima-media thickness in young adults: the cardiovascular risk in Young Finns Study
-
Kivimaki M., Lawlor D.A., Juonala M., Smith G.D., Elovainio M., Keltikangas-Jarvinen L., et al. Lifecourse socioeconomic position, C-reactive protein, and carotid intima-media thickness in young adults: the cardiovascular risk in Young Finns Study. Arterioscler Thromb Vasc Biol 2005, 25:2197-2202.
-
(2005)
Arterioscler Thromb Vasc Biol
, vol.25
, pp. 2197-2202
-
-
Kivimaki, M.1
Lawlor, D.A.2
Juonala, M.3
Smith, G.D.4
Elovainio, M.5
Keltikangas-Jarvinen, L.6
-
49
-
-
42949136965
-
C-reactive protein increases plasminogen activator inhibitor-1 expression in human endothelial cells
-
Chen C., Nan B., Lin P., Yao Q. C-reactive protein increases plasminogen activator inhibitor-1 expression in human endothelial cells. Thromb Res 2008, 122:125-133.
-
(2008)
Thromb Res
, vol.122
, pp. 125-133
-
-
Chen, C.1
Nan, B.2
Lin, P.3
Yao, Q.4
-
50
-
-
26244451415
-
Rho/Rho-kinase pathway contributes to C-reactive protein-induced plasminogen activator inhibitor-1 expression in endothelial cells
-
Nakakuki T., Ito M., Iwasaki H., Kureishi Y., Okamoto R., Moriki N., et al. Rho/Rho-kinase pathway contributes to C-reactive protein-induced plasminogen activator inhibitor-1 expression in endothelial cells. Arterioscler Thromb Vasc Biol 2005, 25:2088-2093.
-
(2005)
Arterioscler Thromb Vasc Biol
, vol.25
, pp. 2088-2093
-
-
Nakakuki, T.1
Ito, M.2
Iwasaki, H.3
Kureishi, Y.4
Okamoto, R.5
Moriki, N.6
-
51
-
-
26244467021
-
C-reactive protein decreases tissue plasminogen activator activity in human aortic endothelial cells: evidence that C-reactive protein is a procoagulant
-
Singh U., Devaraj S., Jialal I. C-reactive protein decreases tissue plasminogen activator activity in human aortic endothelial cells: evidence that C-reactive protein is a procoagulant. Arterioscler Thromb Vasc Biol 2005, 25:2216-2221.
-
(2005)
Arterioscler Thromb Vasc Biol
, vol.25
, pp. 2216-2221
-
-
Singh, U.1
Devaraj, S.2
Jialal, I.3
-
52
-
-
24344490417
-
C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation
-
Cirillo P., Golino P., Calabro P., Cali G., Ragni M., De Rosa S., et al. C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation. Cardiovasc Res 2005, 68:47-55.
-
(2005)
Cardiovasc Res
, vol.68
, pp. 47-55
-
-
Cirillo, P.1
Golino, P.2
Calabro, P.3
Cali, G.4
Ragni, M.5
De Rosa, S.6
-
53
-
-
42249092845
-
C-reactive protein enhances tissue factor expression by vascular smooth muscle cells: mechanisms and in vivo significance
-
Wu J., Stevenson M.J., Brown J.M., Grunz E.A., Strawn T.L., Fay W.P. C-reactive protein enhances tissue factor expression by vascular smooth muscle cells: mechanisms and in vivo significance. Arterioscler Thromb Vasc Biol 2008, 28:698-704.
-
(2008)
Arterioscler Thromb Vasc Biol
, vol.28
, pp. 698-704
-
-
Wu, J.1
Stevenson, M.J.2
Brown, J.M.3
Grunz, E.A.4
Strawn, T.L.5
Fay, W.P.6
-
54
-
-
20244363246
-
Activation of inflammation and coagulation after infusion of C-reactive protein in humans
-
Bisoendial R.J., Kastelein J.J.P., Levels J.H.M., Zwaginga J.J., van den Bogaard B., Reitsma P.H., et al. Activation of inflammation and coagulation after infusion of C-reactive protein in humans. Circ Res 2005, 96:714-716.
-
(2005)
Circ Res
, vol.96
, pp. 714-716
-
-
Bisoendial, R.J.1
Kastelein, J.J.P.2
Levels, J.H.M.3
Zwaginga, J.J.4
Van Den Bogaard, B.5
Reitsma, P.H.6
-
55
-
-
0043075885
-
Increased thrombosis following injury in human C-reactive protein transgenic mice
-
Danenberg H., Szalai A., Swaminathan R., Peng L., Chen Z., Seifert P., et al. Increased thrombosis following injury in human C-reactive protein transgenic mice. Circulation 2003, 108:512-515.
-
(2003)
Circulation
, vol.108
, pp. 512-515
-
-
Danenberg, H.1
Szalai, A.2
Swaminathan, R.3
Peng, L.4
Chen, Z.5
Seifert, P.6
-
56
-
-
72449145874
-
C-reactive protein and the risk of stent thrombosis and cardiovascular events after drug-eluting stent implantation
-
Park D.W., Yun S.C., Lee J.Y., Kim W.J., Kang S.J., Lee S.W., et al. C-reactive protein and the risk of stent thrombosis and cardiovascular events after drug-eluting stent implantation. Circulation 2009, 120:1987-1995.
-
(2009)
Circulation
, vol.120
, pp. 1987-1995
-
-
Park, D.W.1
Yun, S.C.2
Lee, J.Y.3
Kim, W.J.4
Kang, S.J.5
Lee, S.W.6
-
57
-
-
82955189275
-
A point-of-care platelet function assay and C-reactive protein for prediction of major cardiovascular events after drug-eluting stent implantation
-
Park D.-W., Lee S.-W., Yun S.-C., Song H.-G., Ahm J.-M., Lee J.-Y., et al. A point-of-care platelet function assay and C-reactive protein for prediction of major cardiovascular events after drug-eluting stent implantation. J Am Coll Cardiol 2011, 58:2630-2639.
-
(2011)
J Am Coll Cardiol
, vol.58
, pp. 2630-2639
-
-
Park, D.-W.1
Lee, S.-W.2
Yun, S.-C.3
Song, H.-G.4
Ahm, J.-M.5
Lee, J.-Y.6
-
58
-
-
77953673449
-
Relationship between baseline inflammatory markers, antiplatelet therapy, and adverse cardiac events after percutaneous coronary intervention: an analysis from the clopidogrel for the reduction of events during observation trial
-
Dosh K., Berger P.B., Marso S., van Lente F., Brennan D.M., Charnigo R., et al. Relationship between baseline inflammatory markers, antiplatelet therapy, and adverse cardiac events after percutaneous coronary intervention: an analysis from the clopidogrel for the reduction of events during observation trial. Circ Cardiovasc Interv 2009, 2:503-512.
-
(2009)
Circ Cardiovasc Interv
, vol.2
, pp. 503-512
-
-
Dosh, K.1
Berger, P.B.2
Marso, S.3
van Lente, F.4
Brennan, D.M.5
Charnigo, R.6
-
59
-
-
84883292827
-
Statin therapy to reduce stent thrombosis in acute myocardial infarction patients with elevated high-sensitivity C-reactive protein
-
[Epub ahead of print]
-
Jeong H.C., Ahn Y., Hong Y.J., Kim J.H., Jeong M.H., Kim Y.J., et al. Statin therapy to reduce stent thrombosis in acute myocardial infarction patients with elevated high-sensitivity C-reactive protein. Int J Cardiol 2012, [Epub ahead of print].
-
(2012)
Int J Cardiol
-
-
Jeong, H.C.1
Ahn, Y.2
Hong, Y.J.3
Kim, J.H.4
Jeong, M.H.5
Kim, Y.J.6
-
60
-
-
20144379879
-
Statins reduce interleukin-6-induced C-reactive protein in human hepatocytes: new evidence for direct antiinflammatory effects of statins
-
Arnaud C., Burger F., Steffens S., Veillard N.R., Nguyen T.H., Trono D., et al. Statins reduce interleukin-6-induced C-reactive protein in human hepatocytes: new evidence for direct antiinflammatory effects of statins. Arterioscler Thromb Vasc Biol 2005, 25:1231-1236.
-
(2005)
Arterioscler Thromb Vasc Biol
, vol.25
, pp. 1231-1236
-
-
Arnaud, C.1
Burger, F.2
Steffens, S.3
Veillard, N.R.4
Nguyen, T.H.5
Trono, D.6
-
61
-
-
65449138698
-
A randomized trial of rosuvastatin in the prevention of venous thromboembolism
-
Glynn R.J., Danielson E., Fonseca F.A., Genest J., Gotto A.M., Kastelein J.J., et al. A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N Engl J Med 2009, 360:1851-1861.
-
(2009)
N Engl J Med
, vol.360
, pp. 1851-1861
-
-
Glynn, R.J.1
Danielson, E.2
Fonseca, F.A.3
Genest, J.4
Gotto, A.M.5
Kastelein, J.J.6
-
62
-
-
84857009319
-
Relation of hs-CRP and BNP levels with the atrial spontaneous echo contrast and thrombi in permanent atrial fibrillation patients with different etiologies
-
Sahin T., Acar E., Celikyurt U., Kilic T., Kozdag G., Agacdiken A., et al. Relation of hs-CRP and BNP levels with the atrial spontaneous echo contrast and thrombi in permanent atrial fibrillation patients with different etiologies. Med Sci Monit 2012, 18:CR78-CR87.
-
(2012)
Med Sci Monit
, vol.18
-
-
Sahin, T.1
Acar, E.2
Celikyurt, U.3
Kilic, T.4
Kozdag, G.5
Agacdiken, A.6
-
63
-
-
33646366683
-
Targeting C-reactive protein for the treatment of cardiovascular disease
-
Pepys M.B., Hirschfield G.M., Tennent G.A., Gallimore J.R., Kahan M.C., Bellotti V., et al. Targeting C-reactive protein for the treatment of cardiovascular disease. Nature 2006, 440:1217-1221.
-
(2006)
Nature
, vol.440
, pp. 1217-1221
-
-
Pepys, M.B.1
Hirschfield, G.M.2
Tennent, G.A.3
Gallimore, J.R.4
Kahan, M.C.5
Bellotti, V.6
-
64
-
-
0043154640
-
Nitric oxide synthases: domain structure and alignment in enzyme function and control
-
Ghosh D.K., Salerno J.C. Nitric oxide synthases: domain structure and alignment in enzyme function and control. Front Biosci 2003, 8:d193-d209.
-
(2003)
Front Biosci
, vol.8
-
-
Ghosh, D.K.1
Salerno, J.C.2
-
65
-
-
34247093334
-
Nitric oxide and the vascular endothelium
-
Moncada S., Higgs E.A. Nitric oxide and the vascular endothelium. Handb Exp Pharmacol 2006, 213-254.
-
(2006)
Handb Exp Pharmacol
, pp. 213-254
-
-
Moncada, S.1
Higgs, E.A.2
-
66
-
-
0034852620
-
The ten most commonly asked questions about endothelial function in cardiology
-
Verma S., Anderson T.J. The ten most commonly asked questions about endothelial function in cardiology. Cardiol Rev 2001, 9:250-252.
-
(2001)
Cardiol Rev
, vol.9
, pp. 250-252
-
-
Verma, S.1
Anderson, T.J.2
-
67
-
-
0037126012
-
Demonstration That C-Reactive Protein Decreases eNOS Expression and Bioactivity in Human Aortic Endothelial Cells
-
Venugopal S.K., Devaraj S., Yuhanna I., Shaul P., Jialal I. Demonstration That C-Reactive Protein Decreases eNOS Expression and Bioactivity in Human Aortic Endothelial Cells. Circulation 2002, 106:1439-1441.
-
(2002)
Circulation
, vol.106
, pp. 1439-1441
-
-
Venugopal, S.K.1
Devaraj, S.2
Yuhanna, I.3
Shaul, P.4
Jialal, I.5
-
68
-
-
0037161360
-
Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein
-
Verma S., Li S.H., Badiwala M.V., Weisel R.D., Fedak P.W., Li R.K., et al. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation 2002, 105:1890-1896.
-
(2002)
Circulation
, vol.105
, pp. 1890-1896
-
-
Verma, S.1
Li, S.H.2
Badiwala, M.V.3
Weisel, R.D.4
Fedak, P.W.5
Li, R.K.6
-
69
-
-
2442422177
-
C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease
-
Verma S., Kuliszewski M.A., Li S.-H., Szmitko P.E., Zucco L., Wang C.-H., et al. C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation 2004, 109:2058-2067.
-
(2004)
Circulation
, vol.109
, pp. 2058-2067
-
-
Verma, S.1
Kuliszewski, M.A.2
Li, S.-H.3
Szmitko, P.E.4
Zucco, L.5
Wang, C.-H.6
-
70
-
-
0037143638
-
A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis
-
Verma S., Wang C.H., Li S.H., Dumont A.S., Fedak P.W., Badiwala M.V., et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 2002, 106:913-919.
-
(2002)
Circulation
, vol.106
, pp. 913-919
-
-
Verma, S.1
Wang, C.H.2
Li, S.H.3
Dumont, A.S.4
Fedak, P.W.5
Badiwala, M.V.6
-
71
-
-
32444439891
-
FcgammaRIIB mediates C-reactive protein inhibition of endothelial NO synthase
-
Mineo C., Gormley A.K., Yuhanna I.S., Osborne-Lawrence S., Gibson L.L., Hahner L., et al. FcgammaRIIB mediates C-reactive protein inhibition of endothelial NO synthase. Circ Res 2005, 97:1124-1131.
-
(2005)
Circ Res
, vol.97
, pp. 1124-1131
-
-
Mineo, C.1
Gormley, A.K.2
Yuhanna, I.S.3
Osborne-Lawrence, S.4
Gibson, L.L.5
Hahner, L.6
-
72
-
-
0036845090
-
C-reactive protein relaxes human vessels in vitro
-
Sternik L., Samee S., Schaff H.V., Zehr K.J., Lerman L.O., Holmes D.R., et al. C-reactive protein relaxes human vessels in vitro. Arterioscler Thromb Vasc Biol 2002, 22:1865-1868.
-
(2002)
Arterioscler Thromb Vasc Biol
, vol.22
, pp. 1865-1868
-
-
Sternik, L.1
Samee, S.2
Schaff, H.V.3
Zehr, K.J.4
Lerman, L.O.5
Holmes, D.R.6
-
73
-
-
33947188132
-
Biological effects of C-reactive protein are not due to endotoxin contamination: Evidence from toll like receptor 4 knock-down human aortic endothelial cells
-
Dasu M.R., Devaraj S., Du Clos T.W., Jialal I. Biological effects of C-reactive protein are not due to endotoxin contamination: Evidence from toll like receptor 4 knock-down human aortic endothelial cells. J Lipid Res 2007, 48:509-512.
-
(2007)
J Lipid Res
, vol.48
, pp. 509-512
-
-
Dasu, M.R.1
Devaraj, S.2
Du Clos, T.W.3
Jialal, I.4
-
74
-
-
33947188132
-
Biological effects of C-reactive protein are not due to endotoxin contamination: Evidence from toll like receptor 4 knock-down human aortic endothelial cells
-
Dasu M.R., Devaraj S., Du Clos T.W., Jialal I. Biological effects of C-reactive protein are not due to endotoxin contamination: Evidence from toll like receptor 4 knock-down human aortic endothelial cells. J Lipid Res 2007, 48(3):509-512.
-
(2007)
J Lipid Res
, vol.48
, Issue.3
, pp. 509-512
-
-
Dasu, M.R.1
Devaraj, S.2
Du Clos, T.W.3
Jialal, I.4
-
75
-
-
56949091352
-
Impaired endothelial function in C-reactive protein overexpressing mice
-
Teoh H., Quan A., Lovren F., Wang G., Tirgari T., Szmitko P.E., et al. Impaired endothelial function in C-reactive protein overexpressing mice. Atherosclerosis 2008, 201:318-325.
-
(2008)
Atherosclerosis
, vol.201
, pp. 318-325
-
-
Teoh, H.1
Quan, A.2
Lovren, F.3
Wang, G.4
Tirgari, T.5
Szmitko, P.E.6
-
77
-
-
0017084547
-
Prostaglandin endoperoxide and thromboxane generating systems and their selective inhibition
-
Moncada S., Needleman P., Bunting S., Vane J.R. Prostaglandin endoperoxide and thromboxane generating systems and their selective inhibition. Prostaglandins 1976, 12:323-335.
-
(1976)
Prostaglandins
, vol.12
, pp. 323-335
-
-
Moncada, S.1
Needleman, P.2
Bunting, S.3
Vane, J.R.4
-
78
-
-
0033524421
-
Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2
-
McAdam B.F., Catella-Lawson F., Mardini I.A., Kapoor S., Lawson J.A., FitzGerald G.A. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. Proc Natl Acad Sci U S A 1999, 96:272-277.
-
(1999)
Proc Natl Acad Sci U S A
, vol.96
, pp. 272-277
-
-
McAdam, B.F.1
Catella-Lawson, F.2
Mardini, I.A.3
Kapoor, S.4
Lawson, J.A.5
FitzGerald, G.A.6
-
79
-
-
0032948948
-
Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids
-
Catella-Lawson F., McAdam B., Morrison B.W., Kapoor S., Kujubu D., Antes L., et al. Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids. J Pharmacol Exp Ther 1999, 289:735-741.
-
(1999)
J Pharmacol Exp Ther
, vol.289
, pp. 735-741
-
-
Catella-Lawson, F.1
McAdam, B.2
Morrison, B.W.3
Kapoor, S.4
Kujubu, D.5
Antes, L.6
-
80
-
-
42449093389
-
Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis
-
Solomon S.D., Wittes J., Finn P.V., Fowler R., Viner J., Bertagnolli M.M., et al. Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis. Circulation 2008, 117:2104-2113.
-
(2008)
Circulation
, vol.117
, pp. 2104-2113
-
-
Solomon, S.D.1
Wittes, J.2
Finn, P.V.3
Fowler, R.4
Viner, J.5
Bertagnolli, M.M.6
-
81
-
-
33748417874
-
CRP promotes monocyte-endothelial cell adhesion via Fc{gamma} receptors in human aortic endothelial cells under static and shear flow conditions
-
Devaraj S., Davis B., Simon S.I., Jialal I. CRP promotes monocyte-endothelial cell adhesion via Fc{gamma} receptors in human aortic endothelial cells under static and shear flow conditions. Am J Physiol Heart Circ Physiol 2006, 291:H1170-H1176.
-
(2006)
Am J Physiol Heart Circ Physiol
, vol.291
-
-
Devaraj, S.1
Davis, B.2
Simon, S.I.3
Jialal, I.4
-
82
-
-
67949083606
-
Aspirin reduces the prothrombotic activity of C-reactive protein
-
Grad E., Golomb M., Koroukhov N., Lawson J.A., Lotan C., Fitzgerald G.A., et al. Aspirin reduces the prothrombotic activity of C-reactive protein. J Thromb Haemost 2009, 7:1393-1400.
-
(2009)
J Thromb Haemost
, vol.7
, pp. 1393-1400
-
-
Grad, E.1
Golomb, M.2
Koroukhov, N.3
Lawson, J.A.4
Lotan, C.5
Fitzgerald, G.A.6
-
83
-
-
0020692577
-
Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man
-
FitzGerald G.A., Oates J.A., Hawiger J., Maas R.L., Roberts L.J., Lawson J.A., et al. Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. J Clin Invest 1983, 71:676-688.
-
(1983)
J Clin Invest
, vol.71
, pp. 676-688
-
-
FitzGerald, G.A.1
Oates, J.A.2
Hawiger, J.3
Maas, R.L.4
Roberts, L.J.5
Lawson, J.A.6
-
84
-
-
84866617133
-
Role of thromboxane receptor in C-reactive protein-induced thrombosis
-
Grad E., Pachino R.M., Fitzgerald G.A., Danenberg H.D. Role of thromboxane receptor in C-reactive protein-induced thrombosis. Arterioscler Thromb Vasc Biol 2012, 32:2468-2478.
-
(2012)
Arterioscler Thromb Vasc Biol
, vol.32
, pp. 2468-2478
-
-
Grad, E.1
Pachino, R.M.2
Fitzgerald, G.A.3
Danenberg, H.D.4
-
85
-
-
34447528855
-
FcgammaRIIa mediates C-reactive protein-induced inflammatory responses of human vascular smooth muscle cells by activating NADPH oxidase 4
-
Ryu J., Lee C.W., Shin J.A., Park C.S., Kim J.J., Park S.J., et al. FcgammaRIIa mediates C-reactive protein-induced inflammatory responses of human vascular smooth muscle cells by activating NADPH oxidase 4. Cardiovasc Res 2007, 75:555-565.
-
(2007)
Cardiovasc Res
, vol.75
, pp. 555-565
-
-
Ryu, J.1
Lee, C.W.2
Shin, J.A.3
Park, C.S.4
Kim, J.J.5
Park, S.J.6
-
86
-
-
0037426399
-
C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle
-
Wang C.-H., Li S.-H., Weisel R.D., Fedak P.W.M., Dumont A.S., Szmitko P., et al. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation 2003, 107:1783-1790.
-
(2003)
Circulation
, vol.107
, pp. 1783-1790
-
-
Wang, C.-H.1
Li, S.-H.2
Weisel, R.D.3
Fedak, P.W.M.4
Dumont, A.S.5
Szmitko, P.6
-
87
-
-
79955006782
-
CRP enhances soluble LOX-1 release from macrophages by activating TNF-alpha converting enzyme
-
Zhao X.Q., Zhang M.W., Wang F., Zhao Y.X., Li J.J., Wang X.P., et al. CRP enhances soluble LOX-1 release from macrophages by activating TNF-alpha converting enzyme. J Lipid Res 2011, 52:923-933.
-
(2011)
J Lipid Res
, vol.52
, pp. 923-933
-
-
Zhao, X.Q.1
Zhang, M.W.2
Wang, F.3
Zhao, Y.X.4
Li, J.J.5
Wang, X.P.6
-
88
-
-
1542289579
-
The mechanism of oxidative stress stabilization of the thromboxane receptor in COS-7 cells
-
Valentin F., Field M.C., Tippins J.R. The mechanism of oxidative stress stabilization of the thromboxane receptor in COS-7 cells. J Biol Chem 2004, 279:8316-8324.
-
(2004)
J Biol Chem
, vol.279
, pp. 8316-8324
-
-
Valentin, F.1
Field, M.C.2
Tippins, J.R.3
-
89
-
-
67650544152
-
Activation-dependent stabilization of the human thromboxane receptor: role of reactive oxygen species
-
Wilson S.J., Cavanagh C.C., Lesher A.M., Frey A.J., Russell S.E., Smyth E.M. Activation-dependent stabilization of the human thromboxane receptor: role of reactive oxygen species. J Lipid Res 2009, 50:1047-1056.
-
(2009)
J Lipid Res
, vol.50
, pp. 1047-1056
-
-
Wilson, S.J.1
Cavanagh, C.C.2
Lesher, A.M.3
Frey, A.J.4
Russell, S.E.5
Smyth, E.M.6
-
90
-
-
17144369225
-
Macrophage conditioned medium induces the expression of C-reactive protein in human aortic endothelial cells: potential for paracrine/autocrine effects
-
Venugopal S.K., Devaraj S., Jialal I. Macrophage conditioned medium induces the expression of C-reactive protein in human aortic endothelial cells: potential for paracrine/autocrine effects. Am J Pathol 2005, 166:1265-1271.
-
(2005)
Am J Pathol
, vol.166
, pp. 1265-1271
-
-
Venugopal, S.K.1
Devaraj, S.2
Jialal, I.3
-
91
-
-
0142087611
-
Inflammatory Cytokines Stimulated C-Reactive Protein Production by Human Coronary Artery Smooth Muscle Cells
-
Calabro P., Willerson J.T., Yeh E.T.H. Inflammatory Cytokines Stimulated C-Reactive Protein Production by Human Coronary Artery Smooth Muscle Cells. Circulation 2003, 108:1930-1932.
-
(2003)
Circulation
, vol.108
, pp. 1930-1932
-
-
Calabro, P.1
Willerson, J.T.2
Yeh, E.T.H.3
-
92
-
-
0037258396
-
The kidney as a second site of human C-reactive protein formation in vivo
-
Jabs W.J., Logering B.A., Gerke P., Kreft B., Wolber E.M., Klinger M.H., et al. The kidney as a second site of human C-reactive protein formation in vivo. Eur J Immunol 2003, 33:152-161.
-
(2003)
Eur J Immunol
, vol.33
, pp. 152-161
-
-
Jabs, W.J.1
Logering, B.A.2
Gerke, P.3
Kreft, B.4
Wolber, E.M.5
Klinger, M.H.6
-
93
-
-
0034704261
-
Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer's disease
-
Yasojima K., Schwab C., McGeer E.G., McGeer P.L. Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer's disease. Brain Res 2000, 887:80-89.
-
(2000)
Brain Res
, vol.887
, pp. 80-89
-
-
Yasojima, K.1
Schwab, C.2
McGeer, E.G.3
McGeer, P.L.4
-
94
-
-
33646690511
-
Endogenous expression of C-reactive protein is increased in active (ulcerated noncomplicated) human carotid artery plaques
-
Krupinski J., Turu M.M., Martinez-Gonzalez J., Carvajal A., Juan-Babot J.O., Iborra E., et al. Endogenous expression of C-reactive protein is increased in active (ulcerated noncomplicated) human carotid artery plaques. Stroke 2006, 37:1200-1204.
-
(2006)
Stroke
, vol.37
, pp. 1200-1204
-
-
Krupinski, J.1
Turu, M.M.2
Martinez-Gonzalez, J.3
Carvajal, A.4
Juan-Babot, J.O.5
Iborra, E.6
-
95
-
-
0141727734
-
Local generation of C-reactive protein in diseased coronary artery venous bypass grafts and normal vascular tissue
-
Jabs W.J., Theissing E., Nitschke M., Bechtel J.F.M., Duchrow M., Mohamed S., et al. Local generation of C-reactive protein in diseased coronary artery venous bypass grafts and normal vascular tissue. Circulation 2003, 108:1428-1431.
-
(2003)
Circulation
, vol.108
, pp. 1428-1431
-
-
Jabs, W.J.1
Theissing, E.2
Nitschke, M.3
Bechtel, J.F.M.4
Duchrow, M.5
Mohamed, S.6
-
96
-
-
33846862465
-
Widespread vascular production of C-reactive protein (CRP) and a relationship between serum CRP, plaque CRP and intimal hypertrophy
-
Wilson A.M., Swan J.D., Ding H., Zhang Y., Whitbourn R.J., Gurry J., et al. Widespread vascular production of C-reactive protein (CRP) and a relationship between serum CRP, plaque CRP and intimal hypertrophy. Atherosclerosis 2007, 191:175-181.
-
(2007)
Atherosclerosis
, vol.191
, pp. 175-181
-
-
Wilson, A.M.1
Swan, J.D.2
Ding, H.3
Zhang, Y.4
Whitbourn, R.J.5
Gurry, J.6
-
97
-
-
10744224994
-
Interaction of oxidative stress and inflammatory response in coronary plaque instability: important role of C-reactive protein
-
Kobayashi S., Inoue N., Ohashi Y., Terashima M., Matsui K., Mori T., et al. Interaction of oxidative stress and inflammatory response in coronary plaque instability: important role of C-reactive protein. Arterioscler Thromb Vasc Biol 2003, 23:1398-1404.
-
(2003)
Arterioscler Thromb Vasc Biol
, vol.23
, pp. 1398-1404
-
-
Kobayashi, S.1
Inoue, N.2
Ohashi, Y.3
Terashima, M.4
Matsui, K.5
Mori, T.6
-
98
-
-
80052339522
-
Endothelial C-reactive protein increases platelet adhesion under flow conditions
-
Grad E., Pachino R.M., Danenberg H.D. Endothelial C-reactive protein increases platelet adhesion under flow conditions. Am J Physiol Heart Circ Physiol 2011, 301:H730-H736.
-
(2011)
Am J Physiol Heart Circ Physiol
, vol.301
-
-
Grad, E.1
Pachino, R.M.2
Danenberg, H.D.3
-
99
-
-
68049112203
-
Platelets affect the structure and function of C-reactive protein
-
Filep J.G. Platelets affect the structure and function of C-reactive protein. Circ Res 2009, 105:109-111.
-
(2009)
Circ Res
, vol.105
, pp. 109-111
-
-
Filep, J.G.1
-
100
-
-
30944470352
-
C-reactive protein: a family of proteins to regulate cardiovascular function
-
Schwedler S.B., Filep J.G., Galle J., Wanner C., Potempa L.A. C-reactive protein: a family of proteins to regulate cardiovascular function. Am J Kidney Dis 2006, 47:212-222.
-
(2006)
Am J Kidney Dis
, vol.47
, pp. 212-222
-
-
Schwedler, S.B.1
Filep, J.G.2
Galle, J.3
Wanner, C.4
Potempa, L.A.5
-
101
-
-
84866535851
-
Circulating microparticles generate and transport monomeric C-reactive protein in patients with myocardial infarction
-
Habersberger J., Strang F., Scheichl A., Htun N., Bassler N., Maria-Merivita R., et al. Circulating microparticles generate and transport monomeric C-reactive protein in patients with myocardial infarction. Cardiovasc Res 2012, 96:64-72.
-
(2012)
Cardiovasc Res
, vol.96
, pp. 64-72
-
-
Habersberger, J.1
Strang, F.2
Scheichl, A.3
Htun, N.4
Bassler, N.5
Maria-Merivita, R.6
-
102
-
-
26244441368
-
Loss of pentameric symmetry in C-reactive protein induces interleukin-8 secretion through peroxynitrite signaling in human neutrophils
-
Khreiss T., Jozsef L., Potempa L.A., Filep J.G. Loss of pentameric symmetry in C-reactive protein induces interleukin-8 secretion through peroxynitrite signaling in human neutrophils. Circ Res 2005, 97:690-697.
-
(2005)
Circ Res
, vol.97
, pp. 690-697
-
-
Khreiss, T.1
Jozsef, L.2
Potempa, L.A.3
Filep, J.G.4
|